Autoimmune

Latest News
May 23rd 2024

FDA Approves Belimumab Autoinjector for Children With Systemic Lupus Erythematosus

May 16th 2024

Corticosteroid Treatment Associated With Fast, Improved Outcomes in Patients With Sydenham Chorea

May 9th 2024

Celiac Disease Increases Mortality Among Patients With Microscopic Colitis, Study Says

May 3rd 2024

Lower Antioxidant Intake Linked to Endometriosis-Related Rheumatoid Arthritis Risk in Women of Childbearing Age

April 30th 2024

Bristol Myers Squibb, Repertoire Enter $1.8 Billion Deal to Develop Vaccines for Autoimmune Diseases

Video Interviews
View All
April 1st 2024

Dr Jeff Stark: Bimekizumab Shows Long-Term Efficacy When Used to Treat Patients With HS

March 26th 2024

Dr Jeff Stark: Patients With Hidradenitis Suppurativa Have Improved Pain Management With Bimekizumab

Continuing Medical Education
View All
November 21st 2024

Emerging Concepts and Approaches in the Treatment of Food Allergy: What Managed Care Professionals Need to Know

1.5 Credits / Immunology, Allergy
November 21st 2024

Exploring Innovative Approaches in Myasthenia Gravis and the Specialty Pharmacist’s Role in Optimizing Value-Based Treatment

1.5 Credits / Immunology
November 21st 2024

Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care

1.5 Credits / Dermatology, Immunology
November 21st 2024

Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis

1.0 Credit / Immunology, Neurology
November 21st 2024

Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

1.0 Credit / Gastroenterology, Immunology, Rare Diseases
November 21st 2024

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory
November 21st 2024

Managed Care Approaches to Individualize Treatment of Hereditary Angioedema

1.0 Credit / Immunology
November 21st 2024

From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care

1.5 Credits / Allergy, Immunology

More News

Martina Porter, MD, vice chair of research, Department of Dermatology, Beth Israel Deaconess Medical Center
April 18th 2024

Dr Martina Porter Shares Findings on Ruxolitinib Cream in Patients With HS

Pearl Steinzor
Martina Porter, MD, FAAD, vice chair of research, Department of Dermatology, Beth Israel Deaconess Medical Center, discusses efficacy and safety findings from a phase 2 study.
COVID-19 diagnostic test-Ralf-stock.adobe.com.jpeg
April 15th 2024

COVID-19 Linked to Long-Term Risk of Autoimmune Inflammatory Rheumatic Diseases

Pearl Steinzor
The risk for incident autoimmune inflammatory rheumatic disease (AIRD) was greater among patients with a history of COVID-19 infection.
Pregnant patient | Image Credit: Pituk - stock.adobe.com
April 8th 2024

Methotrexate, Leflunomide Treatment Associated With Increased Possibility of Adverse Pregnancy Outcomes in Patients With RA

Brooke McCormick
Pregnant female patients with rheumatoid arthritis (RA) treated with methotrexate and leflunomide within 3 months of conception faced an increased possibility of adverse pregnancy outcomes, specifically stillbirth or abortion.
patient in hospital bed | Image Credit: Gorodenkoff - stock.adobe.com
April 5th 2024

Study: Patients With SLE, AF Experience Higher In-Hospital Mortality Rate

Brooke McCormick
Patients with systemic lupus erythematosus (SLE) and atrial fibrillation (AF) exhibited elevated risks of severe cardiac complications, alongside increased in-hospital mortality, costs, and length of stay (LOS).
Autoimmune disease concept | Anar Mammadov - stock.adobe.com
March 28th 2024

FDA Approves Ravulizumab-cwvz for Rare Autoimmune Disease

Pearl Steinzor
Ravulizumab-cwvz (Ultomiris) received a label expansion by the FDA for the treatment of adult neuromyelitis optica spectrum disorder in patients with anti–aquaporin-4 antibodies after trials results showed it could prevent relapses.
woman applying sunscreen on her shoulder | Image Credit: Lea - stock.adobe.com
March 21st 2024

Gaps in Skincare Knowledge, Sun Protection Practice Exist Among Patients With Lupus

Brooke McCormick
This poster reported that photoprotection management of lupus is unaffordable for some patients, which may have an impact on sunscreen application frequency.
patient with vitiligo covering her face with her hands | Image Credit: Savory - stock.adobe.com
March 19th 2024

Autoimmune Comorbidities Prevalent in Patients With Vitiligo

Brooke McCormick
Posters reported the prevalence of autoimmune comorbidities among patients with vitiligo, demonstrating the need for earlier screenings and updated clinical guidelines.
telehealth appointment | Image Credit: insta_photos - stock.adobe.com
March 13th 2024

Study: Telehealth Has Significant Potential to Manage, Deliver Care for Rheumatic Diseases

Brooke McCormick
Telehealth, which increased 63-fold from 2019 to 2020, has potential for managing and delivering care to patients with rheumatic diseases.
AJMC
January 19th 2024

Racial/Ethnic Differences in Autoimmune Disease Prevalence in US Claims/EHR Data

Sunali D. Goonesekera, MS Surup Dey, MPH Shilpa Thakur, MPH Evelyn P. Davila, PhD, MPH
This analysis uses claims and electronic health records from 2021 to examine racial and ethnic variations in immune-mediated inflammatory diseases in the United States.
COVID-19 Vaccine Bottle With Syringe | image credit: myskin - stock.adobe.com
December 31st 2023

Patients With RA Receiving DMARDs Have Reduced COVID-19 Vaccine Immune Responses, Study Finds

Kyle Munz
A cross-sectional study finds that patients with rheumatoid arthritis receiving disease-modifying antirheumatic drugs (DMARDs) exhibit a reduced immune response to the COVID-19 vaccine compared with controls.
Man With Lupus Erythematosus | image credit: velimir - stock.adobe.com
December 27th 2023

Afimetoran Shown to Be Safe, Well-Tolerated for Patients With Cutaneous Lupus Erythematosus

Tim Smith
This new late-breaking data presented at ACR 2023 was the first clinical evidence indicating efficacy of afimetoran for those with cutaneous lupus erythematosus (CLE).
Woman Enduring Rheumatoid Arthritis | image credit: doucefleur - stock.adobe.com
December 23rd 2023

Training Initiative for Management of Rheumatoid Arthritis Shows Promise in Native American Communities

Tim Smith
This new program was designed to be a scalable model for the formulation of similar initiatives in communities known to have limited access to specialized care for rheumatic conditions.
Man With Finger Pain | image credit: sebra - stock.adobe.com
December 21st 2023

Non-Inflammatory Factors May Affect Disease Measurement and Treatment Targets in RA, Study Finds

Kyle Munz
An observational registry study revealed that inflammatory disease activity is not the only factor influencing the achievement of treatment targets for patients with rheumatoid arthritis (RA).
Top 5 Autoimmune Content 2023
December 15th 2023

Top 5 Most-Read Autoimmune Pieces of 2023

Kyle Munz
This year’s most-read articles on autoimmune diseases explored comorbidities with cardiovascular disease, the value of new forms of monitoring and therapy, and more.
Rheumatoid Arthritis Flare | image credit: doucefleur - stock.adobe.com
December 8th 2023

Patients With RA in Remission Withdrawing From TNF Inhibition Show Flare Increases

Tim Smith
New data presented at ACR 2023 highlighted the differences in rates of flares and Boolean 2.0 remission rates compared to patients with rheumatoid arthritis who continued a tumor necrosis factor inhibitor (TNFi).
Autoimmune Thyroid Disease Model | image credit: Jo Panuwat D - stock.adobe.com
November 28th 2023

Disease-Modifying Antirheumatic Drugs Linked to Decreased Risk for Autoimmune Thyroid Disease

Kyle Munz
A nationwide cohort study linked biologic disease-modifying antirheumatic drugs with decreased risks for the onset of autoimmune thyroid disease in patients with rheumatoid arthritis.
Meta-Analysis Concept | image credit: Planet Studio - stock.adobe.com
November 24th 2023

Network Meta-Analysis Validates the Use of Methotrexate in RA Compared With Other Treatments

Kyle Munz
A network meta-analysis confirmed the efficacy of methotrexate for patients with rheumatoid arthritis (RA) and validated it as the primary reference conventional synthetic disease-modifying antirheumatic drug for treatment in this population.
Pregnant Woman Animated | image credit: See Less - stock.adobe.com
November 22nd 2023

Autoimmune Skin Conditions Can Increase Likelihood of Maternal and Infant Pregnancy Complications

Kyle Munz
A retrospective analysis reveals that pregnant patients with autoimmune skin diseases have higher risks for adverse pregnancy outcomes.
Doctor Writing on Prescription Pad | image credit: cameravit - stock.adobe.com
November 18th 2023

Telitacicept Efficacious, Safe in Treating Patients With RA, Inadequate MTX Response

Tim Smith
In these phase 3 findings presented at ACR 2023, the safety and efficacy of this drug was proven in American College of Rheumatology-20 (ACR20), ACR50, and Disease Activity Score in 28 joints with Erythrocyte Sedimentation Rate responses.
RA Xray Concept | image credit: stockdevil -stocke.adobe.com
November 8th 2023

Rituximab Demonstrates Potential Efficacy in Treatment of Special Forms of RA

Kyle Munz
A retrospective analysis suggested that administering rituximab to patients with rheumatoid arthritis complicated by lymphoma, systemic vasculitis, or extra-articular lesions was associated with improved outcomes.
Woman Sitting with Rheumatoid Arthritis | image credit: Valentina - stock.adobe.com
October 27th 2023

Immune-Mediated Inflammatory Diseases Increase Despite Available Treatment

Abigail Brooks, MA
Results highlighted a growing number of incident cases of asthma, inflammatory bowel disease, multiple sclerosis, psoriasis, atopic dermatitis, and rheumatoid arthritis from 1990 to 2019.
Aortic Stenosis Defined | image credit: Vitalii Vodolazskyi - stock.adobe.com
October 25th 2023

Patients With RA Are at Increased Risk for Aortic Stenosis, Study Suggests

Kyle Munz
Results from a retrospective, matched cohort study suggested that valvular heart disease and aortic stenosis may contribute to disparities in cardiovascular disease–related mortality in patients with rheumatoid arthritis (RA).
Polymyalgia rheumatica | Image credit: tashatuvango - stock.adobe.com
October 13th 2023

Sarilumab Demonstrates Sustained Remission in Patients With Polymyalgia Rheumatica

Lana Pine
At week 52, sustained remission was observed in significantly more patients receiving sarilumab compared with placebo.
COVID-19 Virus | sdecoret - stock.adobe.com
October 9th 2023

COVID-19 Infection Associated With Risk of Autoimmune, Autoinflammatory Disorders

Kyle Munz
A retrospective, population-based study reveals a possible association between COVID-19 infection and autoimmune and autoinflammatory outcomes.
Lupus Written With Marker | MP Studio - stock.adobe.com
October 4th 2023

IFGBP-2 Levels Indicative of Renal Prognosis in Pediatric Lupus Nephritis, Study Finds

Kyle Munz
In a cross-sectional study, insulin growth factor binding protein 2 (IFGBP-2) showed promise as a prognosis biomarker for renal disease in pediatric lupus nephritis (LN).
Lung disease | Image credit: Crystal light - stock.adobe.com
September 29th 2023

ACR Introduces Guidelines for Treatment, Management of ILD in Patients With Rheumatic Disease

Lana Pine
Guidelines aim to help the identification of ILD in patients with rheumatic disease and aid in improving the management of patients.
Page with title aortic stenosis and glasses | Image Credit: Vitalii Vodolazskyi
September 20th 2023

Rheumatoid Arthritis Is a Risk Factor for Aortic Stenosis, Study Finds

Kyle Munz
Researchers add to evidence suggesting that inflammatory factors contribute to increased risk for valvular heart diseases, such as aortic stenosis, in patients with rheumatoid arthritis.
Dementia | Image credit: freshidea - stock.adobe.com
September 14th 2023

Infections, Rather Than Inflammation or Autoimmune Disease, Associated With Dementia Development

Kyle Munz
A nationwide study conducted in Denmark found an association between dementia incidence and previous exposure to infection, but the potential impacts of systemic inflammation or autoimmune diseases on dementia incidence were not as clear.
Group supporting one another
September 8th 2023

Social Support Linked to Better Quality of Life in Patients With Lupus

Lana Pine
Patients with SLE who reported being more satisfied in their lives were more likely to have higher physical and mental component summary scores.
Study: Mental Health Symptoms Underestimated in Patients With Rheumatic Disease
August 31st 2023

Study: Mental Health Symptoms Underestimated in Patients With Rheumatic Disease

Kyle Munz
Researchers analyzed patient and clinician perspectives on neuropsychiatric (NP) symptom occurrence and found discrepancies potentially impacting patient care.
12>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo